Belluscura (FRA:9VQ) Gross Profit : €0.06 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Gross Profit?

Belluscura's gross profit for the six months ended in Jun. 2023 was €-0.05 Mil. Belluscura's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was €0.06 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Belluscura's gross profit for the six months ended in Jun. 2023 was €-0.05 Mil. Belluscura's Revenue for the six months ended in Jun. 2023 was €0.34 Mil. Therefore, Belluscura's Gross Margin % for the quarter that ended in Jun. 2023 was -15.38%.

Belluscura had a gross margin of -15.38% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

During the past 5 years, the highest Gross Margin % of Belluscura was 11.22%. The lowest was -12.34%. And the median was 0.90%.

Belluscura Gross Profit Historical Data

The historical data trend for Belluscura's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Gross Profit Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Gross Profit

-0.01

0.01

-0.05

0.06

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Gross Profit	Get a 7-Day Free Trial				-	-0.05	-0.05	0.12	-0.05

Competitive Comparison of Belluscura's Gross Profit

For the Medical Devices subindustry, Belluscura's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Belluscura's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Gross Profit distribution charts can be found below:

* The bar in red indicates where Belluscura's Gross Profit falls into.

Belluscura Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Belluscura's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )	=	Revenue	-	Cost of Goods Sold
	=	1.32	-	1.256
	=	0.06

Belluscura's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0.338	-	0.39
	=	-0.05

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.06 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Belluscura's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )	=	Gross Profit (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	-0.05	/	0.338
	=	-15.38 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Belluscura (FRA:9VQ) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Belluscura had a gross margin of -15.38% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

Belluscura Gross Profit Related Terms

Thank you for viewing the detailed overview of Belluscura's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines